LIVE ONLINE Conference Programme

default

Loading

Covid Research - Part 2

05 Nov 2021
Covid Research

(Timings are in Greenwich Mean Time - add session to your diary using link below)

Add-on Chinese Medicine for Coronavirus Disease 2019: A Retrospective Cohort

Objective: Previous studies showed that the effect of antivirals for COVID-19 was promising but varied across patient population, and was modest among severe cases. Chinese Medicine (CM) was extensively used to treat COVID-19 in China. We aimed to evaluate the real-world effectiveness of add-on semi-individualized CM during the outbreak.

Co-Authors:

Dr Zixin Shu - PhD candidate - Beijing Jiaotong University
Mr Kai Chang - PhD candidate - Beijing Jiaotong University
Professor Baoyan Liu - Professor - China Academy of Chinese Medical Sciences
Prof Xuezhong Zhou - Professor - Beijing Jiaotong University
Dr Xiaodong Li - Deputy Head - Hubei Provincial Hospital of Traditional Chinese Medicine

 

Speakers
Dr Kam Wa Chan, Post-doctoral Fellow, University of Hong Kong - Hong Kong

The joint congress for ESIM and ISCMR:

Organised in association with:

Gold Sponsors:


 

Silver Sponsors:


 

Supported by: